On January 5, 2024, Neocannbio was invited to the “2024 New Year's greetings ceremony for scientists and information, broadcasting and telecommunications professionals” at the Korea Institute of Science and Technology (KIST) as a company representing biotechnology, and introduced the treatment for epilepsy developed with medical hemp and other products.